🔗 Share this article

As America continues making unprecedented revisions to its vaccination schedules, one figure has surfaced in a surprising turn: Dr. Tracy Beth Høeg, a Danish American sports physician and epidemiologist who first made her name by questioning COVID-19 vaccines during the pandemic and has concentrated on alleged deaths after COVID-19 vaccination in her recent time at the FDA.

Scheduled Overhauls to Childhood Immunization Schedule

Health officials had intended to reveal major revisions to the childhood vaccination calendar recently, synchronizing the US with the Danish national calendar, sources say – a major change that would put the US out of step with many the global community with no evidence for public health gain. The announcement has been delayed until the coming year.

Instead of Vinay Prasad, Dr. Høeg is scheduled to address the audience at the event. She was newly appointed temporary leader of the FDA’s Center for Drug Evaluation and Research (CDER), the fifth individual to head the division this year.

Consolidating Power at the Agency

Høeg's temporary position may indicate a strengthened alliance between the drug and vaccine branches as Dr. Høeg and Prasad consolidate power at the agency – and it suggests a increased emphasis upon reevaluating long-standing vaccines at the FDA.

Høeg has frequently advocated for ending some pediatric vaccine recommendations in the US so as to align more like the Danish model, a country with nationalized medicine and a citizenry about the population of the state of Wisconsin.

In her initial comments, she has continued to focus on vaccines – typically the purview of Prasad, director of the FDA’s Center for Biologics Evaluation and Research (CBER) – rather than drug regulation.

Doubts Over Qualifications

Høeg has no obvious background in pharmaceutical research, approval processes or administrative roles, which has been customary for past heads of the CBER. She has been employed at the FDA as a top consultant to the FDA chief and the vaccine center since earlier this year.

“It seems she lacks to have the necessary background” for running the drug-regulation department, stated a neurologist and psychiatrist. “She’s never run a randomized controlled trial. She has no expertise in leading a sizeable institution. She is not an expert in drug approvals.”

Past commissioners of the center would “understand regulatory frameworks and the underlying principles of pharmaceutical innovation”, commented a former acting FDA commissioner. “Clearly, she doesn’t have the type of experience that previous people who led CBER have had.”

The drug center has an enormous range of responsibilities at the FDA, Woodcock stated.

“Many people just focuses on the innovative therapies, but the generic program clears a multitude of off-brand pharmaceuticals. There is also a biosimilars program, non-prescription drug unit and more, and every single one need to be looked after,” Dr. Woodcock explained. “The thing you overlook, that is the part that I always told people is going to cause problems.”

Furthermore, a substantial management component to the position, which manages in excess of 5,000 staff members. “It is a huge management job, if you perform it correctly,” Woodcock concluded.

Official Statement and Controversial Policies

In response to questions about Dr. Høeg's fitness for the role and whether this appointment indicates increased cooperation among agency officials on vaccines, a press secretary stated that the “inquiries are based on incorrect presumptions”.

“This background matches the duties of her position,” the spokesperson stated, noting the time Høeg spent guiding the FDA commissioner on “pharmaceutical safety and approval science, including computational safety modeling and immunization monitoring”.

In her interim role, Høeg assumes responsibility for the commissioner’s recently launched expedited review system, a contentious one-day medication authorization process that reportedly concerned her predecessors. “How are these therapies being chosen for this expedited pathway? Who is making the calls?” Howard said. “There is a lot of lack of transparency going on at the agency right now.”

Overall, he said, “the agency appears to be shifting towards more relaxed rules of all drugs, aside from shots.”

Public Past Work on Immunizations

Regarding immunizations, Dr. Høeg has a clearer, if troubling, history, Howard have noted. She released a study using unconfirmed public submissions to assess the rate of heart inflammation following Covid immunization. She advised the Florida top health official Dr. Joseph Ladapo, who reportedly have changed statistics to indicate COVID-19 vaccinations are riskier than they are.

Included in her “wish list” for the new government encompassed revising rules for new vaccines and ending “unnecessary” immunizations, she said after the election on a online show. At the agency, Dr. Høeg has according to sources suggested preventing adolescent males from getting COVID-19 vaccines.

“She is an complete dogmatist who commences with her preconceived notions and tailors the evidence to fit the science in a extremely deceptive, dishonest way,” Dr. Howard said.

Taking Control and a “Revenge Tour”

Høeg joined fellow dissenters, {like|